COVID-19 expert panel recommends Serum Institute s Covishield for emergency usage; DCGI to take final call firstpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from firstpost.com Daily Mail and Mail on Sunday newspapers.
An expert panel on Covid-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended grant of permission for restricted emergency use of Oxford Covid-19 vaccine Covishield in India, subject to certain regulatory provisions, official sources said.
As for Bharat Biotech, the Subject Expert Committee (SEC) on Covid-19 of the CDSCO asked the firm to expedite volunteer recruitment for the ongoing clinical trial and said it may conduct interim efficacy analysis for further consideration of restricted emergency use approval for its vaccine Covaxin, they stated.
The SEC, which earlier had sought additional safety, immunogenicity and efficacy data from SII and Bharat Biotech, deliberated on their applications seeking emergency use authorisation (EUA) for their shots on Wednesday, and met again on Friday to review the matter.
India set to approve its first Covid vaccine; nationwide dry run tomorrow thenorthlines.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thenorthlines.com Daily Mail and Mail on Sunday newspapers.
First Indigenous Pneumonia Vaccine To Be Launched Next Week: Report First Indigenous Pneumonia Vaccine To Be Launched Next Week: Report Serum Institute has conducted the phase 1, 2 and 3 clinical trials of the vaccine in India and African nation Gambia.
Serum Institute has conducted the phase 1, 2 and 3 clinical trials of the vaccine. (Representational)
New Delhi:
The first indigenous vaccine against pneumonia, developed by the Serum Institute of India (SII), is slated to be launched by Union Health Minister Harsh Vardhan and made available in the domestic market early next week, official sources said.
According to the sources, the vaccine will be much more affordable than the existing ones manufactured by two foreign companies.
Updated Dec 24, 2020 | 10:54 IST
While India does have access to pneumonia vaccines, the locally developed vaccine is likely to be much cheaper than the two foreign ones in use. First indigenous vaccine against Pneuomonia developed by Serum Institute of India; to be launched next week | Photo Credit: iStock Images
New Delhi: Upholding the status of being the largest vaccine producer in the world, India now has an indigenous vaccine against Pneumonia as well. The first Indian vaccine against Pneumonia has been developed by the Serum Institute of India. The vaccine will soon be launched by the Union Health Minister Harsh Vardhan, and will also be made available in the domestic markers as early as next week, sources confirmed on Wednesday.